Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2010
05/19/2010CN101709083A Fibrinolytic protein from scorpion tails, preparation method and application thereof
05/19/2010CN101709082A Method for preparing ziconotide
05/19/2010CN101709081A Method for extracting cottonseed protein from cottonseed meal
05/19/2010CN101709080A Synthetic peptide vaccine for resisting porcine circovirus and preparation method thereof
05/19/2010CN101709075A High-efficiency purifying method of engineering fly agglutinin
05/19/2010CN101245344B Eriocheir sinensis lipotropism polyoses factor gene and encoding protein and application
05/19/2010CN101153057B Protein for improving plants fastness and accelerating plant growth and encoding gene thereof
05/19/2010CN101113448B Agkistrodon halys ussuriensis disintegrin site-directed mutants cDNA clone, expression and protein preparation method and application thereof
05/19/2010CN101063130B Recombined protein having phenotypic knock-out effect on chemotropism factor receptor CXCR4 and its construction method
05/19/2010CN101063103B Hainan sporic scorpion antibiotic and preparation method and application
05/19/2010CN101058812B Rice SNARE protein gene OsNPSN11 and application thereof
05/18/2010US7718870 Plants and seeds of hybrid corn variety CH771816
05/18/2010US7718869 Plants and seeds of hybrid corn variety CH355718
05/18/2010US7718868 Plants and seeds of corn variety CV319521
05/18/2010US7718859 Plants and seeds of corn variety CV391950
05/18/2010US7718855 Inbred corn line SY0705W
05/18/2010US7718851 transgenic plants for use in generation of human milk proteins in seeds; transforming a monocotyledonous plant with a chimeric gene having a protein-coding sequence encoding a protein normally present in human milk under the control of a seed maturation-specific promoter
05/18/2010US7718850 Methods and means for delaying seed shattering in plants
05/18/2010US7718845 Production of growth hormone in the milk of a transgenic bovine and methods of purification of the growth hormone from the milk
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718785 Mutations in the SLC40A1 gene associated to impaired iron homeostasis
05/18/2010US7718783 cDNA molecule of a mammalian ELF3 gene; associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alukwd
05/18/2010US7718779 Prophylactic and therapeutic monoclonal antibodies
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718773 treatment of hyperphosphataemia and cardiovascular diseases or arthritis
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718770 PRO1305-polypeptides
05/18/2010US7718765 orally administered type I collagen (CI) induced tolerance to CI in patients suffering from systemic sclerosis (SSc)
05/18/2010US7718764 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
05/18/2010US7718763 Substrate polyeptides for von Willebrand factor cleaving protease ADAMTS-13
05/18/2010US7718762 stimulate T cytotoxic lymphocytes in a mammal
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/18/2010US7718627 Plasmid comprising nucleotide sequences coding immunoglobulin complementary determining regions specific to tumor antigen (5T4); for use in delivering product and/or nucleotide sequences of interest to tumor; drug delivery
05/18/2010US7718618 preventing, treating a viral infection with a polypeptide biodrug; caused by poxvirus, herpes virus, vaccinia virus, and papillomavirus; treating atopic dermatitis
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718616 Bone growth composition comprising:particulate fibrillar collagen, and calcium phosphate; biocompatibility, synthetic; formed into particles and then into a unitary article; pastes or putties for repairing skeletal defects; mineralization; grinding, milling, cutting, molding, freeze drying
05/18/2010US7718615 Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
05/18/2010US7718613 Armed peptides
05/18/2010US7718609 Rapid acting and long acting insulin combination formulations
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010US7718605 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain
05/18/2010US7718604 Use of IL-22 for the treatment of conditions of metabolic disorders
05/18/2010US7718601 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors
05/18/2010US7718598 preparing cyclic peptides by cyclization of a peptide molecule; linking a cyclic aromatic auxiliary compound 5-nitrosalicylaldehyde to a primary amine nitrogen atom of a peptide; solid phase synthesis; improve in both yields and purity of products
05/18/2010US7718575 Method of selecting HLA-DP4 ligands and the applications thereof
05/18/2010US7718428 using an exogenously-derived colony-stimulating factor 5 hyaluronidase (CSF5hyaluronidase) for treatment of myelosuppression as may occur after irradiation, chemotherapy or other diseases where an increase in leukocyte levels may be beneficial
05/18/2010US7718424 AAV4 vector and uses thereof
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718399 Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment
05/18/2010US7718398 DNA comprising promoter sequence, derived from a wild-type promoter of a methyltrophic yeast, whose transcription efficiency is modulated in comparison to the efficiency of the wild-type promoter by inserting or modifying a DNA binding site
05/18/2010US7718397 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
05/18/2010US7718391 Assays for identifying modulators of rhomboid polypeptides
05/18/2010US7718386 Methods for the diagnosis of diabetes
05/18/2010US7718384 Soluble ErbB3 method of detection
05/18/2010US7718383 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718374 Probes for continuous monitoring of replication; solid phase synthesis; distinguishing in a sample between wild-type, mutant and heterozygous target polynucleotides
05/18/2010US7718183 Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species
05/18/2010US7718182 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy
05/18/2010US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
05/18/2010US7718179 Ostertagia vaccine
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010US7718172 Preparing monoclonal antibody to interleukins polypeptide for treating and preventing inflammatory bowel, crohn's, arthritis and psoriasis disorders
05/18/2010US7718165 live Plasmodium organism that is genetically engineered to disrupt a liver-stage-specific gene function; used for inoculating a vertebrate host against malaria
05/18/2010CA2557882C Defective packaging non-oncoviral vectors based on mpmv and hiv
05/18/2010CA2410413C Fluorescent proteins
05/18/2010CA2378543C Modified human granulocyte-colony stimulating factor and process for producing same
05/18/2010CA2363965C Protein-induced morphogenesis
05/18/2010CA2350327C Methods of purifying recombinant human erythropoietin from cell culture supernatants
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2223090C Improved hapten-peptide conjugates to detect anti-hiv-1 or anti-hiv-2 antibodies
05/18/2010CA2216717C Compositions for the diagnosis, prevention, and treatment of tumor progression
05/18/2010CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems
05/18/2010CA1341605C Synthetic antigen for the detection of aids-related disease
05/17/2010CA2686135A1 Chimeric hirudin proteins
05/15/2010CA2739663A1 Polypeptides that bind trail-r1 and trail-r2
05/14/2010WO2010054362A2 Temperature-induced polynucleotides and uses therefor
05/14/2010WO2010054221A2 Treatment of chronic inflammatory respiratory disorders
05/14/2010WO2010054187A2 Compositions and methods for regulating sas1r
05/14/2010WO2010054096A1 Method for detecting and purifying pancreatic beta cells
05/14/2010WO2010054025A1 Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
05/14/2010WO2010053990A2 Crhr2 peptide agonists and uses thereof
05/14/2010WO2010053986A1 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
05/14/2010WO2010053883A1 Live, attentuated respiratory syncytial virus
05/14/2010WO2010053877A2 Mhc ii associated protein and uses thereof
05/14/2010WO2010053838A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
05/14/2010WO2010053816A2 Biomarkers for diagnosis of breast cancer
05/14/2010WO2010053772A2 Disease-associated antigens and methods of use thereof
05/14/2010WO2010053621A2 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof
05/14/2010WO2010053584A2 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
05/14/2010WO2010053518A2 Methods and compositions for inactivating glutamine synthetase gene expression
05/14/2010WO2010053433A1 Increased expression of specific antigens
05/14/2010WO2010053320A2 Method for delivering cargoes into cells, and peptide for same
05/14/2010WO2010052939A1 Method for detecting epitopes in allergen or candidates for the epitopes, and use of the epitopes or the candidates
05/14/2010WO2010052581A1 Use of inhibitors of plac8 activity for the modulation of adipogenesis
05/14/2010WO2010052341A1 Anti-apoptotic fusion proteins
05/14/2010WO2010052335A1 E. coli bl21 strain lacking a functional group ii capsular gene cluster
05/14/2010WO2010052313A1 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
1 ... 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 ... 2916